Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endarterectomy, Carotid | 32 | 2022 | 110 | 4.470 |
Why?
|
| Carotid Stenosis | 32 | 2022 | 163 | 4.450 |
Why?
|
| Stents | 33 | 2022 | 657 | 2.770 |
Why?
|
| Stroke | 42 | 2023 | 2163 | 2.060 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2021 | 931 | 0.990 |
Why?
|
| Carotid Arteries | 6 | 2015 | 110 | 0.860 |
Why?
|
| Myocardial Infarction | 13 | 2021 | 807 | 0.850 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 143 | 0.730 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 154 | 0.720 |
Why?
|
| Patient Selection | 4 | 2020 | 592 | 0.710 |
Why?
|
| Pandemics | 2 | 2020 | 352 | 0.690 |
Why?
|
| Metabolic Syndrome | 4 | 2014 | 191 | 0.670 |
Why?
|
| Angioplasty | 7 | 2018 | 118 | 0.660 |
Why?
|
| Cerebral Revascularization | 7 | 2019 | 45 | 0.650 |
Why?
|
| Life Style | 4 | 2020 | 338 | 0.630 |
Why?
|
| Anemia, Sickle Cell | 6 | 2022 | 364 | 0.620 |
Why?
|
| Hypertension | 7 | 2021 | 1535 | 0.610 |
Why?
|
| Postoperative Complications | 6 | 2017 | 1615 | 0.550 |
Why?
|
| Prosthesis Implantation | 2 | 2018 | 83 | 0.520 |
Why?
|
| Aged | 40 | 2022 | 14862 | 0.510 |
Why?
|
| Risk Factors | 24 | 2022 | 5731 | 0.480 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 125 | 0.480 |
Why?
|
| Middle Aged | 42 | 2022 | 21147 | 0.460 |
Why?
|
| Treatment Outcome | 26 | 2022 | 7029 | 0.450 |
Why?
|
| Antihypertensive Agents | 4 | 2021 | 498 | 0.430 |
Why?
|
| Diabetes Mellitus | 4 | 2020 | 694 | 0.420 |
Why?
|
| Male | 47 | 2022 | 37321 | 0.410 |
Why?
|
| Humans | 66 | 2023 | 68618 | 0.410 |
Why?
|
| Endovascular Procedures | 4 | 2019 | 366 | 0.400 |
Why?
|
| Skiing | 3 | 2007 | 4 | 0.370 |
Why?
|
| Female | 47 | 2022 | 38074 | 0.370 |
Why?
|
| Blood Pressure | 5 | 2021 | 1451 | 0.360 |
Why?
|
| Aged, 80 and over | 14 | 2022 | 4848 | 0.330 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2019 | 99 | 0.330 |
Why?
|
| Exercise | 1 | 2014 | 658 | 0.320 |
Why?
|
| Carotid Artery Diseases | 3 | 2015 | 83 | 0.320 |
Why?
|
| Heart Diseases | 2 | 2023 | 276 | 0.310 |
Why?
|
| Patient Participation | 2 | 2020 | 146 | 0.300 |
Why?
|
| Credentialing | 3 | 2019 | 23 | 0.280 |
Why?
|
| Risk Assessment | 11 | 2022 | 2007 | 0.260 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 3259 | 0.260 |
Why?
|
| Incidence | 9 | 2019 | 1603 | 0.260 |
Why?
|
| Head Protective Devices | 2 | 2007 | 15 | 0.250 |
Why?
|
| United States | 16 | 2023 | 7367 | 0.240 |
Why?
|
| Clinical Competence | 4 | 2019 | 657 | 0.240 |
Why?
|
| Perioperative Care | 2 | 2015 | 100 | 0.240 |
Why?
|
| Clinical Trials as Topic | 3 | 2022 | 848 | 0.230 |
Why?
|
| Brain Ischemia | 3 | 2019 | 665 | 0.210 |
Why?
|
| Prospective Studies | 12 | 2019 | 3705 | 0.210 |
Why?
|
| Age Factors | 4 | 2019 | 1864 | 0.200 |
Why?
|
| Betacoronavirus | 2 | 2020 | 116 | 0.200 |
Why?
|
| Asymptomatic Diseases | 5 | 2021 | 43 | 0.200 |
Why?
|
| Time Factors | 11 | 2019 | 4655 | 0.200 |
Why?
|
| American Heart Association | 2 | 2023 | 142 | 0.200 |
Why?
|
| Biomarkers | 6 | 2018 | 1593 | 0.190 |
Why?
|
| Guideline Adherence | 2 | 2021 | 287 | 0.190 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 176 | 0.190 |
Why?
|
| Erythrocyte Transfusion | 3 | 2019 | 72 | 0.190 |
Why?
|
| Socioeconomic Factors | 3 | 2020 | 955 | 0.180 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 186 | 0.180 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 940 | 0.180 |
Why?
|
| Logistic Models | 8 | 2016 | 1420 | 0.170 |
Why?
|
| Smoking Prevention | 2 | 2014 | 259 | 0.170 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 84 | 0.170 |
Why?
|
| Research Design | 3 | 2020 | 729 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 504 | 0.170 |
Why?
|
| Risk | 6 | 2017 | 563 | 0.170 |
Why?
|
| Radiography, Interventional | 1 | 2019 | 49 | 0.170 |
Why?
|
| Smoking | 3 | 2020 | 1452 | 0.160 |
Why?
|
| Prevalence | 5 | 2019 | 1619 | 0.160 |
Why?
|
| Endpoint Determination | 1 | 2018 | 82 | 0.160 |
Why?
|
| Dyslipidemias | 2 | 2020 | 98 | 0.160 |
Why?
|
| Cranial Nerve Injuries | 2 | 2015 | 4 | 0.150 |
Why?
|
| Sex Distribution | 3 | 2009 | 274 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2020 | 326 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 772 | 0.140 |
Why?
|
| Anesthesia, Conduction | 1 | 2016 | 14 | 0.130 |
Why?
|
| Survival Analysis | 2 | 2018 | 714 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2016 | 86 | 0.130 |
Why?
|
| Lost to Follow-Up | 1 | 2015 | 7 | 0.130 |
Why?
|
| Age Distribution | 2 | 2008 | 320 | 0.130 |
Why?
|
| Thrombin | 1 | 2015 | 117 | 0.120 |
Why?
|
| Cerebral Angiography | 1 | 2015 | 151 | 0.120 |
Why?
|
| Blood Coagulation | 1 | 2015 | 123 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 129 | 0.120 |
Why?
|
| North America | 3 | 2021 | 112 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 329 | 0.120 |
Why?
|
| Judgment | 1 | 2014 | 40 | 0.120 |
Why?
|
| Geography | 2 | 2019 | 80 | 0.120 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 82 | 0.120 |
Why?
|
| Comorbidity | 3 | 2020 | 1426 | 0.120 |
Why?
|
| Emergency Treatment | 1 | 2014 | 52 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2015 | 205 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2014 | 85 | 0.120 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 123 | 0.110 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 1851 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2013 | 25 | 0.110 |
Why?
|
| Goals | 1 | 2014 | 65 | 0.110 |
Why?
|
| Racism | 1 | 2014 | 59 | 0.110 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 180 | 0.110 |
Why?
|
| Models, Statistical | 2 | 2013 | 448 | 0.110 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 137 | 0.110 |
Why?
|
| Patient Dropouts | 1 | 2013 | 98 | 0.100 |
Why?
|
| Endarterectomy | 1 | 2012 | 22 | 0.100 |
Why?
|
| Bias | 1 | 2013 | 148 | 0.100 |
Why?
|
| Health Promotion | 2 | 2007 | 407 | 0.100 |
Why?
|
| Thrombosis | 1 | 2013 | 218 | 0.100 |
Why?
|
| Sepsis | 1 | 2015 | 233 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2015 | 403 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 233 | 0.100 |
Why?
|
| Electrocardiography | 4 | 2018 | 601 | 0.100 |
Why?
|
| Skin Neoplasms | 2 | 2007 | 375 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 362 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 371 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 514 | 0.100 |
Why?
|
| Proportional Hazards Models | 4 | 2015 | 792 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 425 | 0.100 |
Why?
|
| Odds Ratio | 4 | 2016 | 880 | 0.100 |
Why?
|
| Hospitalization | 2 | 2014 | 978 | 0.100 |
Why?
|
| Spain | 2 | 2021 | 34 | 0.090 |
Why?
|
| Physicians | 1 | 2014 | 324 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 377 | 0.090 |
Why?
|
| Child | 6 | 2019 | 6405 | 0.090 |
Why?
|
| Radiology, Interventional | 1 | 2010 | 21 | 0.090 |
Why?
|
| Education | 1 | 2010 | 83 | 0.090 |
Why?
|
| Ultraviolet Rays | 2 | 2007 | 130 | 0.080 |
Why?
|
| Sunburn | 2 | 2007 | 6 | 0.080 |
Why?
|
| Demography | 1 | 2010 | 279 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 536 | 0.080 |
Why?
|
| Hydroxyurea | 2 | 2019 | 57 | 0.080 |
Why?
|
| Quality of Life | 2 | 2015 | 1515 | 0.080 |
Why?
|
| Attitude | 2 | 2007 | 121 | 0.080 |
Why?
|
| Adult | 8 | 2017 | 21403 | 0.080 |
Why?
|
| Adolescent | 6 | 2022 | 8912 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2011 | 249 | 0.080 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 696 | 0.080 |
Why?
|
| Algorithms | 1 | 2013 | 1196 | 0.070 |
Why?
|
| Southeastern United States | 1 | 2008 | 281 | 0.070 |
Why?
|
| Mortality | 1 | 2008 | 163 | 0.070 |
Why?
|
| Tobacco | 1 | 2007 | 161 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2008 | 158 | 0.070 |
Why?
|
| Canada | 2 | 2020 | 267 | 0.070 |
Why?
|
| Health Planning Guidelines | 1 | 2006 | 23 | 0.070 |
Why?
|
| State Government | 1 | 2006 | 34 | 0.070 |
Why?
|
| Policy Making | 1 | 2006 | 51 | 0.070 |
Why?
|
| Mass Screening | 2 | 2016 | 843 | 0.070 |
Why?
|
| Indians, North American | 1 | 2006 | 64 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2014 | 1034 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2019 | 3187 | 0.070 |
Why?
|
| Health Policy | 1 | 2007 | 221 | 0.060 |
Why?
|
| Recreation | 1 | 2005 | 19 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2019 | 181 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2019 | 2358 | 0.060 |
Why?
|
| Occupational Diseases | 1 | 2005 | 68 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2006 | 127 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2016 | 172 | 0.060 |
Why?
|
| Health Education | 1 | 2007 | 279 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2005 | 122 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2006 | 269 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 546 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2006 | 402 | 0.050 |
Why?
|
| Mammography | 1 | 2006 | 310 | 0.050 |
Why?
|
| Moyamoya Disease | 1 | 2022 | 7 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 273 | 0.050 |
Why?
|
| Colorado | 3 | 2007 | 26 | 0.050 |
Why?
|
| Sex Factors | 2 | 2019 | 1266 | 0.050 |
Why?
|
| Data Collection | 1 | 2003 | 420 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2022 | 115 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2021 | 119 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1465 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 26 | 0.040 |
Why?
|
| Young Adult | 2 | 2022 | 5717 | 0.040 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 95 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 135 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 39 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2014 | 631 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 95 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 767 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 649 | 0.040 |
Why?
|
| Telemedicine | 2 | 2020 | 700 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 101 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 202 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 248 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 7277 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 122 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2018 | 301 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 2077 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 951 | 0.040 |
Why?
|
| Sunscreening Agents | 2 | 2007 | 7 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2016 | 51 | 0.030 |
Why?
|
| Antithrombin III | 1 | 2015 | 23 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2015 | 47 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2015 | 50 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 82 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 424 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 733 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 349 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 152 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 429 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2279 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 260 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 85 | 0.030 |
Why?
|
| Remote Consultation | 1 | 2014 | 50 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 572 | 0.030 |
Why?
|
| Awareness | 1 | 2014 | 81 | 0.030 |
Why?
|
| Informed Consent | 1 | 2015 | 127 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 161 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 249 | 0.030 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2013 | 3 | 0.030 |
Why?
|
| Telephone | 1 | 2014 | 160 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 239 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2015 | 224 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 168 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2014 | 291 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 252 | 0.030 |
Why?
|
| Cognition | 1 | 2017 | 513 | 0.030 |
Why?
|
| Learning Curve | 1 | 2012 | 20 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 2093 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 330 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2012 | 32 | 0.030 |
Why?
|
| Models, Economic | 1 | 2012 | 69 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2014 | 294 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2012 | 106 | 0.030 |
Why?
|
| Markov Chains | 1 | 2012 | 133 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 193 | 0.020 |
Why?
|
| Probability | 1 | 2012 | 245 | 0.020 |
Why?
|
| Troponin T | 1 | 2011 | 16 | 0.020 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 5 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2011 | 32 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 1056 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1140 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 112 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 948 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2800 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 504 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 36 | 0.020 |
Why?
|
| Medicine | 1 | 2010 | 52 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1046 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2012 | 267 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2012 | 346 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 489 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 177 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 168 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2010 | 358 | 0.020 |
Why?
|
| Local Government | 1 | 2007 | 17 | 0.020 |
Why?
|
| Law Enforcement | 1 | 2007 | 10 | 0.020 |
Why?
|
| Public Opinion | 1 | 2007 | 32 | 0.020 |
Why?
|
| Eye Protective Devices | 1 | 2007 | 4 | 0.020 |
Why?
|
| Child Welfare | 1 | 2007 | 53 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 145 | 0.020 |
Why?
|
| Politics | 1 | 2006 | 31 | 0.020 |
Why?
|
| Protective Clothing | 1 | 2005 | 12 | 0.020 |
Why?
|
| Sunlight | 1 | 2005 | 59 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2007 | 502 | 0.020 |
Why?
|
| Forecasting | 1 | 2006 | 277 | 0.020 |
Why?
|
| Focus Groups | 1 | 2005 | 247 | 0.010 |
Why?
|
| Parents | 1 | 2007 | 312 | 0.010 |
Why?
|
| Program Development | 1 | 2005 | 240 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2223 | 0.010 |
Why?
|
| Health Behavior | 1 | 2007 | 458 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 468 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1536 | 0.010 |
Why?
|